Clinical application of rapid diagnostic test kit for SARS-CoV-2 antibodies into the field of patient care

Abstract

Clinical applicability of rapid diagnostic test kit for SARS-CoV-2 antibodies was evaluated. The kit detected antibodies from day 9–56 of illness. IgG bands were observed up to 1: 1000 dilutions. The kit could detect 90.5% of IgG and 61.9% of IgM antibodies of mild febrile patients without pneumonia.

Keywords

• Rapid diagnostic test
• Antibody
• SARS-CoV-2
• Titration
• Point-of-care test